Search Results 6941-6950 of 41538 for oral

  1. A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) - Mayo Clinic

    Participant is taking an oral mTOR inhibitor. Participant has any known or suspected hypersensitivity to cannabinoids or any of the excipients of the ...

  2. Study Of Gastric Cancer And Limited Peritoneal Metastasis Using Robotic Cytoreduction And Hyperthermic Intraperitoneal Chemotherapy - Mayo Clinic

    Adequate contraception consists of oral contraceptive, implantable contraceptives, injectable contraceptives, a double barrier method, or abstinence.

  3. A Study To Evaluate The Safety And Feasibility Of Platelet-rich Plasma To Treat Facetogenic Low Back Pain - Mayo Clinic

    Current opioid use of greater than 50mg oral morphine milligram equivalents per day. No advanced imaging (MRI, CT or lumbar x-ray) of the lumbar spine ...

  4. A Study to Evaluate Pomalidomide to Treat Bleeding in Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    A total of 159 patients will be randomized 2:1 to treatment with oral pomalidomide or matching placebo for 24 weeks. Mean change from baseline to 24 weeks ...

  5. Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

    ... oral hypoglycemic agent). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date information ...

  6. A Study To Evaluate The Effectiveness And Safety Of Ibrexafungerp In Patients With Fungal Diseases That Are Refractory To Or Intolerant Of Standard Antifungal Treatment - Mayo Clinic

    More information. Publications. Ibrexafungerp: A novel oral glucan synthase inhibitor. Davis MR. M R; Donnelley MA. M A; Thompson GR. G R. Medical mycology ...

  7. S0820, Adenoma and Second Primary Prevention Trial - Mayo Clinic

    100 mg per day or ≤ two 325 mg tablets per week. Able to swallow oral medications; Laboratory: WBC ≥ 4.0 x 103/mcL, platelets ≥ 100,000/mcL and hemoglobin ...

  8. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: Research Roundup featured image · Research · New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows ...

  9. Cholecystitis - Symptoms and causes - Mayo Clinic

    This results in a bile buildup that can cause inflammation. Other causes of cholecystitis include bile duct changes, tumors, serious illness and certain ...

  10. Mouth cancer - Doctors and departments - Mayo Clinic

    Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...